Some anxiety medications do show up on drug tests, and others don’t. It depends entirely on which medication you take and which type of test is used. Benzodiazepines like alprazolam (Xanax) and diazepam (Valium) are specifically targeted on many drug panels, while common antidepressants prescribed for anxiety, such as SSRIs and SNRIs, are not. Even medications that aren’t directly screened for can sometimes trigger false positives, complicating results in ways that catch people off guard.
What Standard Drug Tests Screen For
The basic federal workplace drug test, known as a 5-panel test, screens for five categories: amphetamines, cocaine, marijuana, opiates and opioids, and PCP. Benzodiazepines are not included on this standard panel. If your employer or testing organization uses only a 5-panel screen, a benzodiazepine prescription alone would not be flagged.
Many private employers, courts, and treatment programs use expanded panels, though. A 10-panel or 12-panel test typically adds benzodiazepines, barbiturates, and other sedatives to the list. If you take Xanax, Valium, Klonopin, or Ativan, these will be detected on any panel that includes benzodiazepines. Before your test, finding out which panel is being used can save a lot of unnecessary worry.
Which Anxiety Medications Are Detected
Anxiety medications fall into several classes, and their visibility on drug tests varies significantly.
Benzodiazepines are the most commonly flagged. Alprazolam (Xanax), diazepam (Valium), lorazepam (Ativan), and clonazepam (Klonopin) are all controlled substances that show up on any expanded drug panel screening for this class. In oral fluid tests, alprazolam can be detected for up to 2.5 days after use, while diazepam can linger for 7 to 9 days due to its longer-acting metabolites. In urine, detection windows generally range from one to seven days, though chronic or heavy use extends that further. Hair testing pushes the window to approximately 90 days.
SSRIs and SNRIs like sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), and venlafaxine (Effexor) are not controlled substances and are not targeted by any standard drug panel. A lab is not looking for them. However, as explained in the next section, some of these can interfere with results in unexpected ways.
Buspirone (Buspar) is a non-controlled anxiety medication that does not show up on drug tests. It works differently from benzodiazepines and is not screened for on any standard panel.
Beta-blockers like propranolol, sometimes prescribed for performance anxiety or physical symptoms of anxiety, are not controlled substances and are not included on any workplace drug panel.
Hydroxyzine (Vistaril), an antihistamine sometimes used for anxiety, is also not a controlled substance and is not screened for on standard tests.
False Positives From Non-Screened Medications
Here’s where things get tricky. Even if your medication isn’t directly tested for, the initial screening method (called an immunoassay) can sometimes cross-react with structurally similar compounds and produce a false positive. Two anxiety medications are well-documented culprits.
Sertraline (Zoloft) is a well-described cause of false-positive results for benzodiazepines. One retrospective analysis found that 26.5% of false-positive benzodiazepine screens occurred in patients with active sertraline prescriptions. The drug’s package insert acknowledges that sertraline and its metabolite can produce false positives on certain immunoassay platforms at high concentrations. So even though Zoloft is an SSRI, not a benzodiazepine, you could get a result that looks like you’ve been taking one.
Venlafaxine (Effexor) has been linked to false-positive results for PCP. Lab studies have shown that venlafaxine and its main metabolite cross-react with PCP assay reagents. The FDA warns that false-positive PCP results can occur even several days after discontinuing venlafaxine. While these cases are considered rare, they are documented enough to be recognized in the medical literature.
What Happens If You Test Positive With a Prescription
A positive result on the initial immunoassay screen does not automatically mean you’ve failed the test. For regulated testing (federal jobs, transportation, safety-sensitive positions), the process includes a confirmation step and a review by a Medical Review Officer, or MRO.
Confirmation testing uses a more precise method, typically gas chromatography-mass spectrometry, which can distinguish between the actual drug and a cross-reacting substance. This step eliminates most false positives. If the confirmation test is still positive, the MRO contacts you directly for a verification interview. During that conversation, you can provide evidence of a legitimate prescription. If you have a valid, legally prescribed medication that explains the result, the MRO verifies the test as negative. The prescribing physician’s judgment is not questioned during this process.
The MRO also has an obligation to protect your privacy. Before sharing any information about your medication with a third party, you’re given five business days to work with your prescribing doctor if there are concerns about medical qualification or safety risk in your specific role.
For non-regulated testing (most private employers, insurance screenings), the process is less standardized. Some private employers use an MRO; others don’t. If you’re taking a prescribed benzodiazepine and you know the test will include that drug class, having your prescription information readily available can speed up the review process.
How Detection Windows Vary by Test Type
The type of specimen collected affects how far back a test can look. Urine testing is the most common method and generally detects drugs for one to seven days, with longer windows for chronic users. Oral fluid testing has a shorter detection period, typically five to 48 hours for most substances, though some benzodiazepines persist longer. Hair testing has the longest detection window at roughly 90 days, capturing a three-month usage history.
The specific benzodiazepine matters too. Short-acting drugs like alprazolam clear the body faster, while long-acting ones like diazepam produce metabolites that linger for days longer. If you’ve recently stopped a long-acting benzodiazepine, it may still be detectable well after your last dose.
Practical Steps Before a Drug Test
If you take any anxiety medication and have an upcoming drug test, a few things can help you avoid problems. First, find out which panel is being used. A standard 5-panel test won’t flag benzodiazepines at all. Second, bring documentation of your prescriptions to the testing appointment or have it accessible by phone. A current prescription bottle or pharmacy printout showing your name, the prescriber, the medication, and the fill date is typically sufficient.
If you take sertraline or venlafaxine, be aware of the false-positive possibility. You don’t need to stop your medication, but knowing about the cross-reactivity means you won’t be blindsided if the initial screen comes back positive. Confirmation testing will resolve it. If an employer or testing organization doesn’t offer confirmation testing automatically, you have the right to request it.